Hereditary leiomyomatosis and renal-cell cancer (HLRCC) is an inherited disorder characterized by germline pathogenic variants in the gene encoding fumarate hydratase and an increased risk of ...
Participants with PROC who received 1-2 previous lines of therapy were treated with niraparib (200 or 300 mg once daily), dostarlimab (500 mg once every 3 weeks for four 21-day cycles, followed by ...
Jobevne is approved for multiple cancer types, including colorectal, non-small cell lung, and glioblastoma, among others. It functions as a VEGF inhibitor, preventing angiogenesis and restricting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results